[
    [
        {
            "time": "2023-10-05",
            "original_text": "Stock Market Rally Revs To New Highs; Nike, Google, FedEx, Eli Lilly, Amazon In Focus: Weekly Review",
            "features": {
                "keywords": [
                    "Stock Market Rally",
                    "Nike",
                    "Google",
                    "FedEx",
                    "Eli Lilly",
                    "Amazon"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Stock Market Rally Revs To New Highs; Nike, Google, FedEx, Eli Lilly, Amazon In Focus: Weekly Review",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "UPDATE 3-U.S. pauses distribution of Lilly's COVID-19 antibody combination therapy",
            "features": {
                "keywords": [
                    "U.S.",
                    "pauses",
                    "distribution",
                    "Lilly's",
                    "COVID-19",
                    "antibody",
                    "combination",
                    "therapy"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "UPDATE 3-U.S. pauses distribution of Lilly's COVID-19 antibody combination therapy",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "Lilly's (LLY) AD Candidate Gets Breakthrough Therapy Status",
            "features": {
                "keywords": [
                    "Lilly's",
                    "AD",
                    "Candidate",
                    "Breakthrough",
                    "Therapy",
                    "Status"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly's (LLY) AD Candidate Gets Breakthrough Therapy Status",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "Lilly's SURPASS-2 results published in The New England Journal of Medicine show tirzepatide achieved superior A1C and body weight reductions compared to injectable semaglutide in adults with type 2 diabetes",
            "features": {
                "keywords": [
                    "Lilly's",
                    "SURPASS-2",
                    "results",
                    "tirzepatide",
                    "superior",
                    "A1C",
                    "body",
                    "weight",
                    "reductions",
                    "semaglutide",
                    "type",
                    "2",
                    "diabetes"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly's SURPASS-2 results published in The New England Journal of Medicine show tirzepatide achieved superior A1C and body weight reductions compared to injectable semaglutide in adults with type 2 diabetes",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-09",
            "original_text": "Eli Lilly Stock Soared on Alzheimer’s Hopes. Now Wall Street Has Doubts.",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Stock",
                    "Soared",
                    "Alzheimer’s",
                    "Hopes",
                    "Wall",
                    "Street",
                    "Doubts"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly Stock Soared on Alzheimer’s Hopes. Now Wall Street Has Doubts.",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "Eli Lilly Is Going Strong: Here's How to Play It",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Going Strong",
                    "Play It"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Is Going Strong: Here's How to Play It",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]